Dispatch Biotherapeutics
Biotechnology
Founded 2022
Dispatch Biotherapeutics is a cancer immunotherapy biotech developing its first-in-class Flare platform, which combines engineered immunotherapy with a tumor-specific virus to target solid tumors. It emerged from stealth in July 2025 with $216M in funding and was named to the 2025 Endpoints 11 list.
- Flare platform (engineered immunotherapy combined with a tumor-specific virus for solid tumors)
Open roles at Dispatch Biotherapeutics
1 matching role
Unspecified
Philadelphia, Pennsylvania, United States
Director
Salary unavailable
- Computer and Information Systems Managers
- Information Technology
Posted 1 month ago
Source: Greenhouse
Showing 1 of 1 roles